These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38888050)

  • 1. The selective serotonin reuptake inhibitors, sertraline and paroxetine, improve islet beta-cell mass and function in vitro.
    Klaudia T; Naila H; Zekun L; Gavin B; Min Z; Hannah R; Jessica S; Bo L; Persaud SJ
    Diabetes Obes Metab; 2024 Jun; ():. PubMed ID: 38888050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective serotonin reuptake inhibitors (SSRIs) inhibit insulin secretion and action in pancreatic β cells.
    Isaac R; Boura-Halfon S; Gurevitch D; Shainskaya A; Levkovitz Y; Zick Y
    J Biol Chem; 2013 Feb; 288(8):5682-93. PubMed ID: 23275337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commiphora myrrha stimulates insulin secretion from mouse and human islets of Langerhans.
    Al-Romaiyan A; Huang GC; Jones P; Persaud S
    J Ethnopharmacol; 2021 Jan; 264():113075. PubMed ID: 32829055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The selective serotonin reuptake inhibitor fluoxetine has direct effects on beta cells, promoting insulin secretion and increasing beta-cell mass.
    Liu B; Ruz-Maldonado I; Toczyska K; Olaniru OE; Zariwala MG; Hopkins D; Zhao M; Persaud SJ
    Diabetes Obes Metab; 2022 Oct; 24(10):2038-2050. PubMed ID: 35676820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACTH stimulates insulin secretion from MIN6 cells and primary mouse and human islets of Langerhans.
    Al-Majed HT; Jones PM; Persaud SJ; Sugden D; Huang GC; Amiel S; Whitehouse BJ
    J Endocrinol; 2004 Jan; 180(1):155-66. PubMed ID: 14709154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypobaric hypoxia exposure in rats differentially alters antidepressant efficacy of the selective serotonin reuptake inhibitors fluoxetine, paroxetine, escitalopram and sertraline.
    Kanekar S; Sheth CS; Ombach HJ; Olson PR; Bogdanova OV; Petersen M; Renshaw CE; Sung YH; D'Anci KE; Renshaw PF
    Pharmacol Biochem Behav; 2018 Jul; 170():25-35. PubMed ID: 29738811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the potential anti-cancer activity of the antidepressant sertraline in human colon cancer cell lines and in colorectal cancer-xenografted mice.
    Gil-Ad I; Zolokov A; Lomnitski L; Taler M; Bar M; Luria D; Ram E; Weizman A
    Int J Oncol; 2008 Aug; 33(2):277-86. PubMed ID: 18636148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective serotonin reuptake inhibitors reduce the spontaneous activity of dopaminergic neurons in the ventral tegmental area.
    Di Mascio M; Di Giovanni G; Di Matteo V; Prisco S; Esposito E
    Brain Res Bull; 1998 Aug; 46(6):547-54. PubMed ID: 9744293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metallothionein 1 negatively regulates glucose-stimulated insulin secretion and is differentially expressed in conditions of beta cell compensation and failure in mice and humans.
    Bensellam M; Shi YC; Chan JY; Laybutt DR; Chae H; Abou-Samra M; Pappas EG; Thomas HE; Gilon P; Jonas JC
    Diabetologia; 2019 Dec; 62(12):2273-2286. PubMed ID: 31624901
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Lei L; Huan Y; Liu Q; Li C; Cao H; Ji W; Gao X; Fu Y; Li P; Zhang R; Abliz Z; Liu Y; Liu S; Shen Z
    Front Pharmacol; 2022; 13():841981. PubMed ID: 35308210
    [No Abstract]   [Full Text] [Related]  

  • 11. Interactions of Selective Serotonin Reuptake Inhibitors with β-Amyloid.
    Tin G; Mohamed T; Shakeri A; Pham AT; Rao PPN
    ACS Chem Neurosci; 2019 Jan; 10(1):226-234. PubMed ID: 30157623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of selective serotonin reuptake inhibitors on neural crest stem cell formation.
    Vichier-Guerre C; Parker M; Pomerantz Y; Finnell RH; Cabrera RM
    Toxicol Lett; 2017 Nov; 281():20-25. PubMed ID: 28844482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Bayesian net benefit regression model to examine the impact of generic drug entry on the cost effectiveness of selective serotonin reuptake inhibitors in elderly depressed patients.
    Shih YC; Bekele NB; Xu Y
    Pharmacoeconomics; 2007; 25(10):843-62. PubMed ID: 17887806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted pharmacotherapy in depression management: comparative pharmacokinetics of fluoxetine, paroxetine and sertraline.
    Preskorn S
    Int Clin Psychopharmacol; 1994 Jun; 9 Suppl 3():13-9. PubMed ID: 7963446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
    Foster RH; Goa KL
    CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different effects of the selective serotonin reuptake inhibitors fluvoxamine, paroxetine, and sertraline on the pharmacokinetics of fexofenadine in healthy volunteers.
    Saruwatari J; Yasui-Furukori N; Niioka T; Akamine Y; Takashima A; Kaneko S; Uno T
    J Clin Psychopharmacol; 2012 Apr; 32(2):195-9. PubMed ID: 22367658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-clinical drug-drug interactions (DDIs) of gefitinib with/without losartan and selective serotonin reuptake inhibitors (SSRIs): citalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, and venlafaxine.
    Luong TT; Powers CN; Reinhardt BJ; Weina PJ
    Curr Res Pharmacol Drug Discov; 2022; 3():100112. PubMed ID: 35756846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of selective serotonin reuptake inhibitors on three sex steroids in two versions of the aromatase enzyme inhibition assay and in the H295R cell assay.
    Jacobsen NW; Hansen CH; Nellemann C; Styrishave B; Halling-Sørensen B
    Toxicol In Vitro; 2015 Oct; 29(7):1729-35. PubMed ID: 26162595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commiphora myrrha stimulates insulin secretion from β-cells through activation of atypical protein kinase C and mitogen-activated protein kinase.
    Al-Romaiyan A; Masocha W; Oyedemi S; Marafie SK; Huang GC; Jones PM; Persaud SJ
    J Ethnopharmacol; 2023 Feb; 302(Pt B):115937. PubMed ID: 36410575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of beta-cell rest by a Kir6.2/SUR1-selective K(ATP)-channel opener preserves beta-cell insulin stores and insulin secretion in human islets cultured at high (11 mM) glucose.
    Ritzel RA; Hansen JB; Veldhuis JD; Butler PC
    J Clin Endocrinol Metab; 2004 Feb; 89(2):795-805. PubMed ID: 14764798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.